Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q05766

Entry ID Method Resolution Chain Position Source
AF-Q05766-F1 Predicted AlphaFoldDB

No variants for Q05766

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q05766

No associated diseases with Q05766

3 regional properties for Q05766

Type Name Position InterPro Accession
domain Adenylate cyclase class-I, N-terminal domain 7 - 205 IPR024685
conserved_site Adenylate cyclase class-I, conserved site 246 - 257 IPR024686-1
conserved_site Adenylate cyclase class-I, conserved site 602 - 616 IPR024686-2

Functions

Description
EC Number 4.6.1.1 Phosphorus-oxygen lyases
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

2 GO annotations of molecular function

Name Definition
adenylate cyclase activity Catalysis of the reaction: ATP = 3',5'-cyclic AMP + diphosphate.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.

1 GO annotations of biological process

Name Definition
cAMP biosynthetic process The chemical reactions and pathways resulting in the formation of the nucleotide cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate).

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MNYDLFSAQK KVEYLDKLRI ERALSGSSGE FQHVFQLLTL LLHINHPNLP GYVADAPVGI
70 80 90 100 110 120
ADFVISPYQK QYLLTTVPSL EANQSLLPSF SYRSTNAILG VYVMGSIASI SQTPKSDLDT
130 140 150 160 170 180
WVCHRDDLST KEKEALQRKT HLLKNWAKQF NIEINFYLMD QKRFRCFRYA EPLTAENCGS
190 200 210 220 230 240
AQYMLLLDEF YRSAIRLAGK PLLWLHLLIE QEENYESEVE RLVRTQQICL DDWVDFGGLG
250 260 270 280 290 300
QLSANEYFGA SLWQLYKGID APYKSVIKIL LLETYSSEYP NTYLIARQFK EELLTGKLNP
310 320 330 340 350 360
SHHFDPYLAM LQRATRYLTK HNELKRLGFV RRSVYLKATE GMCWQDPNAT NNWRLQHLQK
370 380 390 400 410 420
LIQEWDWSDA LIEELNQRAN WKIKQVKKAH NSLIKFLMLS YRNLVAFARK HKVNSSIMPQ
430 440 450 460 470 480
DISVLTRKLY TAFEELPGKI TLLNPQISLN LSEKNLLFFE VKGSKTFKDG WYVVNQTPSV
490 500 510 520 530 540
AGFVQKRYTE YSESLNKLVA WAYFNRILTA NTDLHIISPN VSLTTLRHFV TDLRLSFPVT
550 560 570 580 590 600
VSSVTNEDLT HACEIRSLIV AVNLTVDPTK KITQVKSRIQ ASDLFSFGPK EESLVGSIDI
610 620 630 640 650 660
TYRNLWNEIR TLHFEGPNAI LLALKVLSNK IHRGAPSPKL IQVFSYSHRY RRTLSNIVTA
670 680 690 700 710 720
LINRCISIQI GDALPPQNNL LRVAGKNWQF FFEERGISLQ EIHSNEELEA TGFDTALQTE
730 740 750 760 770 780
VEEKESALPD TSRTYPPEID HFASEGFLQF FFEDNSDGSF NVYILDEANR IEIYRNCDGQ
790 800 810 820 830
KEKKILEINH IYQSSGLDEN NNPYKIVQRD FNYPQFYQLL LQENGVKIVP FHSRLAMS